{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:40:58Z","timestamp":1789886458612,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jaccao.2023.03.015","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T13:58:19Z","timestamp":1689083899000},"page":"445-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and\u00a0Heart\u00a0Failure"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1764-0242","authenticated-orcid":false,"given":"Pieter F.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Pierre","family":"Aboumsallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-7836","authenticated-orcid":false,"given":"Elles M.","family":"Screever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canxia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bracun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura I.","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Geerlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J.L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van der Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman H.W.","family":"Sillj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4775-9140","authenticated-orcid":false,"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter C.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"10.1016\/j.jaccao.2023.03.015_bib2","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2021.5469","article-title":"The leading causes of death in the US for 2020","volume":"325","author":"Ahmad","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jaccao.2023.03.015_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvz035","article-title":"Common risk factors for heart failure and cancer","volume":"115","author":"Meijers","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.jaccao.2023.03.015_bib4","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/ejhf.2029","article-title":"Common mechanistic pathways in cancer and heart failure. a scientific roadmap on behalf of the translational research committee of the Heart\u00a0Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"22","author":"Boer","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"7835","key":"10.1016\/j.jaccao.2023.03.015_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaccao.2023.03.015_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.trsl.2020.03.008","article-title":"Sex related differences in the pathogenesis of organ fibrosis","volume":"222","author":"Garate-Carrillo","year":"2020","journal-title":"Transl Res"},{"issue":"10","key":"10.1016\/j.jaccao.2023.03.015_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/oxfordjournals.eurheartj.a060749","article-title":"Sex-dependent differences in left ventricular function and structure in chronic pressure overload","volume":"16","author":"Villari","year":"1995","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","article-title":"Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease","volume":"10","author":"Kessler","year":"2019","journal-title":"Biol Sex Differ"},{"issue":"2","key":"10.1016\/j.jaccao.2023.03.015_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188356","article-title":"Fibrosis and cancer: a strained relationship","volume":"1873","author":"Piersma","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"12","key":"10.1016\/j.jaccao.2023.03.015_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/ejhf.407","article-title":"Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH","volume":"17","author":"Meijers","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.jaccao.2023.03.015_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ahj.2014.02.011","article-title":"Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials","volume":"167","author":"Meijers","year":"2014","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.jaccao.2023.03.015_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/biom10030389","article-title":"Galectin-3 as a next-generation biomarker for detecting early stage of various diseases","volume":"10","author":"Hara","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaccao.2023.03.015_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2014.10.009","article-title":"Galectin-3 and heart failure: prognosis, prediction & clinical utility","volume":"443","author":"Filipe","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"14","key":"10.1016\/j.jaccao.2023.03.015_bib14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/heartjnl-2015-308975","article-title":"Serial galectin-3 and future cardiovascular disease in the general population","volume":"102","author":"van der Velde","year":"2016","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12935-018-0668-y","article-title":"Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell Int"},{"issue":"2","key":"10.1016\/j.jaccao.2023.03.015_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","article-title":"Galectin-3 \u2013 a jack-of-all-trades in cancer","volume":"313","author":"Newlaczyl","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaccao.2023.03.015_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2014.01.019","article-title":"Galectin-3 in cancer","volume":"431","author":"Song","year":"2014","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.jaccao.2023.03.015_bib18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1158\/1055-9965.EPI-20-0036","article-title":"Sex differences in cancer incidence and survival: a pan-cancer analysis","volume":"29","author":"Dong","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jaccao.2023.03.015_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fgene.2012.00268","article-title":"Gender differences in cancer susceptibility: an inadequately addressed issue","volume":"3","author":"Dorak","year":"2012","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13293-020-00291-x","article-title":"Sex differences in cancer mechanisms","volume":"11","author":"Rubin","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.hfc.2019.08.005","article-title":"Sex and gender-related issues in heart failure","volume":"16","author":"Romiti","year":"2020","journal-title":"Heart Fail Clin"},{"issue":"5","key":"10.1016\/j.jaccao.2023.03.015_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2012.06.017","article-title":"Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study","volume":"60","author":"Smink","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.jaccao.2023.03.015_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ejhf.669","article-title":"Variability of biomarkers in patients with chronic heart failure and healthy controls","volume":"19","author":"Meijers","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2007\/971816","article-title":"Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the Nationwide Histopathology and Cytopathology Data Network and Archive","volume":"29","author":"Casparie","year":"2007","journal-title":"Anal Cell Pathol"},{"issue":"2","key":"10.1016\/j.jaccao.2023.03.015_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001786","article-title":"Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study","volume":"8","author":"Zwartkruis","year":"2021","journal-title":"Open Heart"},{"issue":"19","key":"10.1016\/j.jaccao.2023.03.015_bib26","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jaccao.2023.03.015_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trsl.2019.02.006","article-title":"The double edge sword of fibrosis in cancer","volume":"209","author":"Chandler","year":"2019","journal-title":"Transl Res"},{"issue":"6","key":"10.1016\/j.jaccao.2023.03.015_bib28","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1434467","article-title":"The role of galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment","volume":"7","author":"Farhad","year":"2018","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.jaccao.2023.03.015_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3892\/br.2016.696","article-title":"Association between circulating galectin-3 levels and the immunological, inflammatory and nutritional parameters in patients with colorectal cancer","volume":"5","author":"Shimura","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jaccao.2023.03.015_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.12659\/MSM.892386","article-title":"Serum galectin-3 as a potential marker for gastric cancer","volume":"21","author":"Li","year":"2015","journal-title":"Med Sci Monit"},{"issue":"2","key":"10.1016\/j.jaccao.2023.03.015_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbcan.2015.03.003","article-title":"Galectin expression in cancer diagnosis and prognosis: a systematic review","volume":"1855","author":"Thijssen","year":"2015","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib32","first-page":"12","article-title":"Galectin-3 inhibition with modified citrus pectin in hypertension","volume":"6","author":"Lau","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"issue":"12","key":"10.1016\/j.jaccao.2023.03.015_bib33","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2020.07.044","article-title":"Sex-specific associations of cardiovascular risk factors and biomarkers with incident heart failure","volume":"76","author":"Suthahar","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jaccao.2023.03.015_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ejhf.1771","article-title":"Sex-related differences in contemporary biomarkers for heart failure: a review","volume":"22","author":"Suthahar","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10.1016\/j.jaccao.2023.03.015_bib35","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.7150\/thno.26055","article-title":"Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production","volume":"8","author":"Du","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.jaccao.2023.03.015_bib36","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.jaccao.2023.03.015_bib37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","article-title":"Fibrosis and heart failure","volume":"19","author":"Segura","year":"2014","journal-title":"Heart Fail Rev"},{"issue":"25","key":"10.1016\/j.jaccao.2023.03.015_bib38","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.jacc.2018.09.076","article-title":"Longitudinal change in galectin-3 and incident cardiovascular outcomes","volume":"72","author":"Ghorbani","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jaccao.2023.03.015_bib39","article-title":"Pectins from various sources inhibit galectin-3-related cardiac fibrosis","volume":"70","author":"Pozder Geb Gehlken","year":"2022","journal-title":"Curr Res Transl Med"},{"issue":"8","key":"10.1016\/j.jaccao.2023.03.015_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/13543776.2021.1903430","article-title":"An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016\u2013present)","volume":"31","author":"Sethi","year":"2021","journal-title":"Expert Opin Ther Pat"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087323001199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087323001199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:56:11Z","timestamp":1762973771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087323001199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2666087323001199"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2023.03.015","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and\u00a0Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2023.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}